The Effect of Origami Activities on Comfort Level and Quality of Life

NCT ID: NCT07296757

Last Updated: 2025-12-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ENROLLING_BY_INVITATION

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-12-08

Study Completion Date

2026-01-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study was conducted to evaluate the effect of origami activity on the comfort levels and quality of life of patients undergoing HD treatment.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients undergoing HD treatment must undergo dialysis 2-3 days a week, spend approximately 4 hours per day at the dialysis center, remain dependent on a center and caregiver throughout the treatment, experience mobility limitations, and experience disruptions in their social relationships. Patients can receive adequate treatment only if their physical, mental, and biochemical well-being are maintained.

Activities implemented by dialysis nurses during hemodialysis can be beneficial for HD patients. Art therapy, which is frequently of interest to individuals (painting, drawing, coloring, mandala painting, mural painting, clay modeling, collage, sculpture, ceramics, and model making), is a therapeutic activity that reduces anxiety, increases awareness, facilitates recovery from trauma, and improves social skills and self-esteem. Its benefits have been proven in various patient groups. Origami art is an art therapy known to provide behavioral, social, emotional, and psychomotor developmental benefits, and its therapeutic effects in HD patients have not been previously studied. In this context, this study aims to make a new scientific contribution to the literature of non-pharmacological nursing interventions by examining the effect of a 12-session origami activity on the comfort level and quality of life of patients undergoing hemodialysis treatment.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hemodialysis Complication

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Hemodialysis Origami Comfort Quality of life

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Experimental: Intervention Group Patients in the intervention group will participate in origami activities three days a week, each lasting approximately 30 minutes.

No intervention: Control Group Patients in the control group will receive an origami activity booklet and origami paper after the study.

Each origami activity will be performed using simple shapes, following the order in the researcher-prepared booklet (with the advice of the origami art instructor).
Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

intervention

group doing origami activities

Group Type EXPERIMENTAL

origami

Intervention Type OTHER

origami activity during a hemodialysis session

Control grup

The group that did not undergo any intervention during hemodialysis and received routine care from nurses

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

origami

origami activity during a hemodialysis session

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 years of age or older,
* Literate,
* Undergoing continuous hemodialysis treatment for at least six months,
* Receiving hemodialysis treatment three days a week,
* No visual impairment,
* No communication or perception problems and able to communicate in Turkish,
* No issues (wounds, arthritis, orthopedic impairments, etc.) in the upper extremities that would prevent paper folding,
* No arteriovenous fistula in the dominant arm used for folding,
* Has not received a psychiatric diagnosis and is not taking psychiatric medication,
* Voluntarily agrees to participate in the study,
* Has not previously participated in an activity such as origami.

Exclusion Criteria

* Receiving dialysis treatment as an outpatient,
* Wishing to withdraw from the study at any stage
Minimum Eligible Age

18 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Kafkas University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Helin ATAY

MsC student

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ayşe Gül Parlak, PhD

Role: STUDY_DIRECTOR

Kafkas University Health Science Faculty

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Van Özel Diyaliz Merkezi

Van, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

KAU-SBF-HA-01

Identifier Type: -

Identifier Source: org_study_id